Trupanion (TRUP) stock price is $28.50, down 0.90% on the day, as of Oct 21, 2026. It has a market cap of $1.25Bn and a P/E ratio of 53.74, and is classified in the Property and Casualty Insurance industry (Financial Services sector).
Enterprise Value
Margins
P/FCF
Key Stats
Market Cap1.25 Bn
P/E53.74
P/S0.82
Div. Yield0.00
Total Debt (Qtr)106.91 Mn
Revenue Growth (1y) (Qtr)11.14
Add ratio to table…
About
Trupanion, Inc. provides medical insurance for cats and dogs in the United States, Canada and certain countries in Continental Europe. The company develops and offers insurance products that are priced to reflect each pet’s unique characteristics and the level of coverage selected. It serves a growing and loyal membership base that generates predictable recurring revenue. Trupanion’s approach combines data analytics with a vertically integrated model that controls…
Trupanion, Inc. provides medical insurance for cats and dogs in the United States, Canada and certain countries in Continental Europe. The company develops and offers insurance products that are priced to reflect each pet’s unique characteristics and the level of coverage selected. It serves a growing and loyal membership base that generates predictable recurring revenue. Trupanion’s approach combines data analytics with a vertically integrated model that controls underwriting, pricing, claims processing and veterinary payments. This integration allows the firm to offer policies that are designed to help pet owners budget for unexpected veterinary expenses while ensuring access to necessary medical care.
Revenue is generated primarily from insurance premiums which the company calls subscription payments from its direct to consumer products. These premiums are collected from pet owners who enroll their cats and dogs in the core Trupanion plan or in partner branded offerings such as Powered by Trupanion Furkin and PHI Direct. In addition the company earns revenue from commissions paid by third party underwriters that sell Trupanion branded policies in select European countries. The other business segment contributes revenue by underwriting policies for third party partners on a business to business basis. This includes the long standing agreement with Pets Best Insurance Services as well as contracts with the U. S. Department of Veterans Affairs and various employer sponsored programs.
The company operates through the following segments: subscription business and other business.
subscription business: This segment provides medical insurance for cats and dogs through direct to consumer offerings and through partnerships that market Powered by Trupanion Furkin and PHI Direct products. It also offers insurance in select European countries where third party underwriters pay commissions to the company. The segment includes the core Trupanion branded product which delivers comprehensive coverage for accidents illnesses and hereditary conditions. Policyholders benefit from a patented software system that enables direct payment to veterinary clinics at the time of service. The segment aims to achieve a target margin before acquiring new pets and seeks to maximize the number of pets enrolled at an internally defined rate of return.
other business: This segment generates revenue from underwriting policies on behalf of third party partners with whom the company has business to business relationships. The largest source of revenue in this segment comes from the long standing contractual relationship as an underwriter for Pets Best Insurance Services. Additional sources include the U. S. Department of Veterans Affairs program and employer sponsored programs designed for companies with animal health related operations. The other business segment targets a lower margin profile than the subscription business and is not considered part of the core growth strategy.
The company holds a strong position in the pet insurance market due to its focus on delivering a high value product that covers a broad range of conditions including congenital and hereditary illnesses. Its main competitors are other pet insurers that offer either limited coverage with low price points or annual plans whose cost rises as the pet ages. Trupanion’s competitive advantages include a superior value proposition derived from its vertically integrated structure which reduces frictional costs, deep relationships with veterinarians built through its Territory Partner network, a proprietary data set spanning over twenty five years that enables precise pricing, and a patented software system that allows direct payment to veterinary clinics at the point of service. These advantages help the firm maintain high retention rates and attract new members through veterinary referrals and word of mouth.
The company serves pet owners whom it refers to as pet parents across North America and selected European markets. It also works with veterinary hospitals that recommend its products to clients and with third party partners that distribute its insurance offerings. Specific partners include Pets Best Insurance Services and the U. S. Department of Veterans Affairs which receive underwriting services from the other business segment. In addition the company collaborates with various employer groups that offer pet insurance as a voluntary benefit to their employees.
Sector:Financial ServicesSector rationaleTrupanion's primary revenue is generated from insurance premiums and underwriting services for pet medical insurance. The company operates as an insurer, controlling underwriting, pricing, and claims processing, which falls squarely within the Financial Services sector's insurance industries.Industries:Property and Casualty InsuranceProperty and Casualty InsurancePrimaryTrupanion underwrites medical insurance policies for cats and dogs, taking on the risk of financial loss from veterinary expenses in exchange for premiums. The company controls its own underwriting, pricing, and claims processing for its direct-to-consumer and B2B segments.Insurance BrokersInsurance BrokersSecondaryIn select European countries, the company earns revenue from commissions paid by third-party underwriters who sell Trupanion branded policies, acting as an intermediary rather than the risk-bearer in those specific markets.Classified using BQ-MICSCIK: 0001371285
Bull & bear
Investment Thesis
▲ Bull case
Trupanion Inc. is well-positioned to capitalize on structural growth in the pet insurance market, driven by the enduring human-animal bond and rising veterinary costs that are transforming pet care from discretionary to essential spending, with management highlighting this dynamic as a meaningful and expanding opportunity that the company is strategically aligning to capture through product innovation and market expansion. The company’s subscription business, which now constitutes over 70% of total revenue, delivered 16% year-over-year growth in Q1 FY26, exceeding the high end of guidance, and achieved a record Q1 adjusted operating margin of 14.2%—up 130 basis points year-over-year—demonstrating improving unit economics and pricing power as monthly average revenue per pet rose 11% to $85.79, reflecting successful value-based pricing and customer acceptance of enhanced coverage tiers. This margin expansion, coupled with a 5% increase in total subscription pets to 1.106 million (including 64,000 in Europe), indicates sustainable organic growth fueled by strong retention at 98.35% and effective lead generation, even as the company lapses challenging comparisons from prior-year hospital partnership growth that temporarily diluted same-store sales but expanded its long-term distribution footprint.
The company’s strategic shift to prioritize Adjusted Operating Income (AOI) as its primary value creation metric is revealing a compounding growth engine, with AOI increasing 29% year-over-year in Q1 FY26 to $40.2 million and management citing a 35% compound annual growth rate over the last two years and 45% over the past decade, signaling that reinvestment of this capital is generating increasingly efficient returns across the business, particularly as operational efficiency initiatives drive combined fixed and variable expenses down to 14.9% of revenue from 15.3% year-over-year, while claims automation rates jumped to 62% from 56%, reducing processing costs and improving member experience without sacrificing margins, thereby freeing up capital for reinvestment in high-return initiatives like the new digital-first product and expanded core offerings in Canada and select U.S. states.
Trupanion’s disciplined capital allocation is strengthening its balance sheet and enhancing financial flexibility, with cash and short-term investments growing to $383.7 million and total debt reduced by $19.5 million year-over-year to $109.3 million, providing a net cash position of over $274 million that can be deployed toward strategic investments, shareholder returns, or weathering macroeconomic volatility, while free cash flow remained stable at $13.7 million despite a reduction in capital expenditures to $0.8 million from $1.9 million, indicating efficient operations and low maintenance capital needs, which, combined with the company’s guiding principle of deploying AOI into high-return opportunities, suggests the potential for accelerated intrinsic value creation through both organic growth and tuck-in acquisitions in adjacent pet health services.
The early rollout of expanded core product offerings in Canada and select U.S. states, featuring flexible deductibles and coinsurance tiers to broaden price points, is showing encouraging early conversion rate improvements without materially shifting customer selection toward lower coverage, indicating that the initiative is successfully expanding access to price-sensitive segments—particularly Millennials and Gen Z pet parents—while preserving the value proposition of the flagship product, and this strategic flexibility, combined with the upcoming digital-first product launch later in FY26, positions Trupanion to tap into a broader addressable market beyond its traditional customer base, potentially unlocking new growth vectors that are not yet fully reflected in current guidance ranges for subscription revenue ($1.119B–$1.135B) or full-year AOI ($173M–$187M).
Trupanion Inc. is well-positioned to capitalize on structural growth in the pet insurance market, driven by the enduring human-animal bond and rising veterinary costs that are transforming pet care from discretionary to essential spending, with management highlighting this dynamic as a meaningful and expanding opportunity that the company is strategically aligning to capture through product innovation and market expansion. The company’s subscription business, which now constitutes over 70% of total revenue, delivered 16% year-over-year growth in Q1 FY26, exceeding the high end of guidance, and achieved a record Q1 adjusted operating margin of 14.2%—up 130 basis points year-over-year—demonstrating improving unit economics and pricing power as monthly average revenue per pet rose 11% to $85.79, reflecting successful value-based pricing and customer acceptance of enhanced coverage tiers. This margin expansion, coupled with a 5% increase in total subscription pets to 1.106 million (including 64,000 in Europe), indicates sustainable organic growth fueled by strong retention at 98.35% and effective lead generation, even as the company lapses challenging comparisons from prior-year hospital partnership growth that temporarily diluted same-store sales but expanded its long-term distribution footprint.
The company’s strategic shift to prioritize Adjusted Operating Income (AOI) as its primary value creation metric is revealing a compounding growth engine, with AOI increasing 29% year-over-year in Q1 FY26 to $40.2 million and management citing a 35% compound annual growth rate over the last two years and 45% over the past decade, signaling that reinvestment of this capital is generating increasingly efficient returns across the business, particularly as operational efficiency initiatives drive combined fixed and variable expenses down to 14.9% of revenue from 15.3% year-over-year, while claims automation rates jumped to 62% from 56%, reducing processing costs and improving member experience without sacrificing margins, thereby freeing up capital for reinvestment in high-return initiatives like the new digital-first product and expanded core offerings in Canada and select U.S. states.
Trupanion’s disciplined capital allocation is strengthening its balance sheet and enhancing financial flexibility, with cash and short-term investments growing to $383.7 million and total debt reduced by $19.5 million year-over-year to $109.3 million, providing a net cash position of over $274 million that can be deployed toward strategic investments, shareholder returns, or weathering macroeconomic volatility, while free cash flow remained stable at $13.7 million despite a reduction in capital expenditures to $0.8 million from $1.9 million, indicating efficient operations and low maintenance capital needs, which, combined with the company’s guiding principle of deploying AOI into high-return opportunities, suggests the potential for accelerated intrinsic value creation through both organic growth and tuck-in acquisitions in adjacent pet health services.
The early rollout of expanded core product offerings in Canada and select U.S. states, featuring flexible deductibles and coinsurance tiers to broaden price points, is showing encouraging early conversion rate improvements without materially shifting customer selection toward lower coverage, indicating that the initiative is successfully expanding access to price-sensitive segments—particularly Millennials and Gen Z pet parents—while preserving the value proposition of the flagship product, and this strategic flexibility, combined with the upcoming digital-first product launch later in FY26, positions Trupanion to tap into a broader addressable market beyond its traditional customer base, potentially unlocking new growth vectors that are not yet fully reflected in current guidance ranges for subscription revenue ($1.119B–$1.135B) or full-year AOI ($173M–$187M).
Trupanion Inc. faces mounting pressure from rising veterinary care costs and adverse loss ratio development, which, despite a reported improvement in the value proposition to 70.8% from 71.8% year-over-year, was achieved only after excluding a $3.1 million adverse development from prior periods that negatively impacted subscription revenue by approximately 120 basis points, suggesting that underlying claims inflation may be outpacing pricing adjustments and reserving practices, and the company’s reliance on AOI as a primary metric obscures the true volatility in underwriting performance, particularly as the blended internal rate of return (IRR) was discontinued due to product mix complexity, removing a key longitudinal view of pet-level profitability that could mask deteriorating cohort returns in newer vintages as the business scales and product diversification increases.
The company’s growth in subscription pets—up only 5% year-over-year to 1.106 million—lags significantly behind the 16% growth in subscription revenue, implying that revenue expansion is being driven primarily by price increases and product mix shifts rather than organic pet acquisition, and this divergence is further underscored by a rise in average pet acquisition cost (excluding MGA) to $315 from $267 year-over-year, a 18% increase that suggests diminishing returns on marketing spend and potential saturation in core channels, especially as management acknowledged that new hospital partnerships are not translating into proportional same-store sales growth, with territory partners forced to juggle “going wide and going deep,” indicating that the efficiency of its distribution network may be degrading as it expands footprint without proportional depth in existing partnerships.
Trupanion’s “other business” segment, which generated $114.6 million in revenue with only $1.8 million of adjusted operating income (a 1.6% margin), continues to represent a drag on overall profitability, and management’s expectation that growth in this segment will decelerate due to the cessation of new pet enrollment with its largest partner in most U.S. states signals a structural decline in this legacy revenue stream, yet the company has not disclosed plans to wind down or restructure this low-margin business, which consumes operational focus and capital that could be more effectively deployed toward higher-return subscription initiatives, creating an opportunity cost that is not fully reflected in the current AOI-centric narrative.
Despite management’s confidence in operational efficiency, the company’s free cash flow remained flat year-over-year at $13.7 million despite a reduction in capital expenditures to $0.8 million from $1.9 million, suggesting that working capital pressures or other cash outflows are offsetting the benefits of lower capex, and this stagnation in cash generation—combined with the narrowing of revenue guidance ranges and increased reliance on a stable 73% U.S./Canadian conversion rate for forecasting—reveals sensitivity to macroeconomic volatility, particularly currency fluctuations, which could disrupt the predictability of AOI generation and undermine the compounding narrative if exchange rate movements deviate from assumptions, especially given the company’s growing international footprint in Europe, where 64,000 subscription pets now reside and where regulatory, competitive, and economic risks are less understood and not adequately hedged in current guidance.
Trupanion Inc. faces mounting pressure from rising veterinary care costs and adverse loss ratio development, which, despite a reported improvement in the value proposition to 70.8% from 71.8% year-over-year, was achieved only after excluding a $3.1 million adverse development from prior periods that negatively impacted subscription revenue by approximately 120 basis points, suggesting that underlying claims inflation may be outpacing pricing adjustments and reserving practices, and the company’s reliance on AOI as a primary metric obscures the true volatility in underwriting performance, particularly as the blended internal rate of return (IRR) was discontinued due to product mix complexity, removing a key longitudinal view of pet-level profitability that could mask deteriorating cohort returns in newer vintages as the business scales and product diversification increases.
The company’s growth in subscription pets—up only 5% year-over-year to 1.106 million—lags significantly behind the 16% growth in subscription revenue, implying that revenue expansion is being driven primarily by price increases and product mix shifts rather than organic pet acquisition, and this divergence is further underscored by a rise in average pet acquisition cost (excluding MGA) to $315 from $267 year-over-year, a 18% increase that suggests diminishing returns on marketing spend and potential saturation in core channels, especially as management acknowledged that new hospital partnerships are not translating into proportional same-store sales growth, with territory partners forced to juggle “going wide and going deep,” indicating that the efficiency of its distribution network may be degrading as it expands footprint without proportional depth in existing partnerships.
Trupanion’s “other business” segment, which generated $114.6 million in revenue with only $1.8 million of adjusted operating income (a 1.6% margin), continues to represent a drag on overall profitability, and management’s expectation that growth in this segment will decelerate due to the cessation of new pet enrollment with its largest partner in most U.S. states signals a structural decline in this legacy revenue stream, yet the company has not disclosed plans to wind down or restructure this low-margin business, which consumes operational focus and capital that could be more effectively deployed toward higher-return subscription initiatives, creating an opportunity cost that is not fully reflected in the current AOI-centric narrative.
Despite management’s confidence in operational efficiency, the company’s free cash flow remained flat year-over-year at $13.7 million despite a reduction in capital expenditures to $0.8 million from $1.9 million, suggesting that working capital pressures or other cash outflows are offsetting the benefits of lower capex, and this stagnation in cash generation—combined with the narrowing of revenue guidance ranges and increased reliance on a stable 73% U.S./Canadian conversion rate for forecasting—reveals sensitivity to macroeconomic volatility, particularly currency fluctuations, which could disrupt the predictability of AOI generation and undermine the compounding narrative if exchange rate movements deviate from assumptions, especially given the company’s growing international footprint in Europe, where 64,000 subscription pets now reside and where regulatory, competitive, and economic risks are less understood and not adequately hedged in current guidance.